These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Outcomes of resection of stage IV rectal cancer with mesorectal excision. Law WL; Chu KW J Surg Oncol; 2006 Jun; 93(7):523-8. PubMed ID: 16705728 [TBL] [Abstract][Full Text] [Related]
24. lymph node ratio as a prognostic factor in patients with stage III rectal cancer treated with total mesorectal excision followed by chemoradiotherapy. Kim YS; Kim JH; Yoon SM; Choi EK; Ahn SD; Lee SW; Kim JC; Yu CS; Kim HC; Kim TW; Chang HM Int J Radiat Oncol Biol Phys; 2009 Jul; 74(3):796-802. PubMed ID: 19289261 [TBL] [Abstract][Full Text] [Related]
25. Randomised clinical trial of adjuvant postoperative RT vs. sequential postoperative RT plus 5-FU and levamisole in patients with stage II-III resectable rectal cancer: a final report. Cafiero F; Gipponi M; Lionetto R; J Surg Oncol; 2003 Jul; 83(3):140-6. PubMed ID: 12827681 [TBL] [Abstract][Full Text] [Related]
26. The effect of circumferential tumor location in clinical outcomes of rectal cancer patients treated with total mesorectal excision. Lee SH; Hernandez de Anda E; Finne CO; Madoff RD; Garcia-Aguilar J Dis Colon Rectum; 2005 Dec; 48(12):2249-57. PubMed ID: 16400512 [TBL] [Abstract][Full Text] [Related]
27. Adjuvant chemotherapy with uracil-tegafur for pathological stage III rectal cancer after mesorectal excision with selective lateral pelvic lymphadenectomy: a multicenter randomized controlled trial. Akasu T; Moriya Y; Ohashi Y; Yoshida S; Shirao K; Kodaira S; Jpn J Clin Oncol; 2006 Apr; 36(4):237-44. PubMed ID: 16675478 [TBL] [Abstract][Full Text] [Related]
28. [Postoperative complications of curative treatment for rectal cancer in males with sphincter-preserving total mesorectal excision]. Szynglarewicz B; Matkowski R; Sydor D; Forgacz J; Pudełko M; Grzebieniak Z Pol Merkur Lekarski; 2007 Nov; 23(137):348-51. PubMed ID: 18361317 [TBL] [Abstract][Full Text] [Related]
29. Total pelvic exenteration with preoperative irradiation for advanced primary and recurrent rectal cancer. Wiig JN; Poulsen JP; Larsen S; Braendengen M; Waehre H; Giercksky KE Eur J Surg; 2002; 168(1):42-8. PubMed ID: 12022371 [TBL] [Abstract][Full Text] [Related]
30. [Preoperative chemoradiotherapy as neoadjuvant therapy for 35 patients with locally advanced lower rectal carcinoma]. Feng HY; Li DC; Lou RC; Zhu Y; Liu LY Zhonghua Wei Chang Wai Ke Za Zhi; 2005 Mar; 8(2):125-8. PubMed ID: 16155821 [TBL] [Abstract][Full Text] [Related]
31. Long-term results of intraoperative presacral electron boost radiotherapy (IOERT) in combination with total mesorectal excision (TME) and chemoradiation in patients with locally advanced rectal cancer. Krempien R; Roeder F; Oertel S; Roebel M; Weitz J; Hensley FW; Timke C; Funk A; Bischof M; Zabel-Du Bois A; Niethammer AG; Eble MJ; Buchler MW; Treiber M; Debus J Int J Radiat Oncol Biol Phys; 2006 Nov; 66(4):1143-51. PubMed ID: 16979835 [TBL] [Abstract][Full Text] [Related]
32. Long-term results of patients with pT2 rectal cancer treated with radiotherapy and transanal endoscopic microsurgical excision. Lezoche E; Guerrieri M; Paganini AM; Feliciotti F World J Surg; 2002 Sep; 26(9):1170-4. PubMed ID: 12209248 [TBL] [Abstract][Full Text] [Related]
33. Local recurrence after mesorectal excision for rectal cancer. Nesbakken A; Nygaard K; Westerheim O; Mala T; Lunde OC Eur J Surg Oncol; 2002 Mar; 28(2):126-34. PubMed ID: 11884047 [TBL] [Abstract][Full Text] [Related]
34. Factors that influence the adequacy of total mesorectal excision for rectal cancer. Jeyarajah S; Sutton CD; Miller AS; Hemingway D; Colorectal Dis; 2007 Nov; 9(9):808-15. PubMed ID: 17441969 [TBL] [Abstract][Full Text] [Related]
36. A simplified tumor regression grade correlates with survival in locally advanced rectal carcinoma treated with neoadjuvant chemoradiotherapy. Beddy D; Hyland JM; Winter DC; Lim C; White A; Moriarty M; Armstrong J; Fennelly D; Gibbons D; Sheahan K Ann Surg Oncol; 2008 Dec; 15(12):3471-7. PubMed ID: 18846402 [TBL] [Abstract][Full Text] [Related]
37. Endoscopic posterior mesorectal resection after transanal local excision of T1 carcinomas of the lower third of the rectum. Zerz A; Müller-Stich BP; Beck J; Linke GR; Tarantino I; Lange J Dis Colon Rectum; 2006 Jun; 49(6):919-24. PubMed ID: 16612534 [TBL] [Abstract][Full Text] [Related]
38. Rectal cancer: the influence of type of operation on local recurrence and survival. Bjerkeset T; Edna TH Eur J Surg; 1996 Aug; 162(8):643-8. PubMed ID: 8891623 [TBL] [Abstract][Full Text] [Related]
39. Optimal surgery time after preoperative chemoradiotherapy for locally advanced rectal cancers. Lim SB; Choi HS; Jeong SY; Kim DY; Jung KH; Hong YS; Chang HJ; Park JG Ann Surg; 2008 Aug; 248(2):243-51. PubMed ID: 18650634 [TBL] [Abstract][Full Text] [Related]
40. Randomized controlled trial of postoperative radiotherapy and short-term time-scheduled 5-fluorouracil against surgery alone in the treatment of Dukes B and C rectal cancer. Norwegian Adjuvant Rectal Cancer Project Group. Tveit KM; Guldvog I; Hagen S; Trondsen E; Harbitz T; Nygaard K; Nilsen JB; Wist E; Hannisdal E Br J Surg; 1997 Aug; 84(8):1130-5. PubMed ID: 9278661 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]